Gene delivery technologies company SIRION Biotech GmbH reported on Monday revenues of EUR3.1m for its vector design and manufacturing service for the first half of 2020.

This marks a growth of 26% when compared to the same period in 2019.

The company added that the prior year figures have been adjusted for a market approval milestone by one of its licensees.

For the whole of 2020 the company projects revenue of approximately EUR11.0m, which would exceed last year's revenue record.